Skip to content

EFFECT OF ERANDADI GHANAVATI OVER KAISHORA GUGGULU AFTER VIRECHAN IN THE PATIENTS OF VATARAKTA (CHRONIC GOUT)

Effect of Erandadighana vati over Kaishora guggulu after Virechan in the management of Vatarakta(Chronic Gout)- A randomised comparative clinical trial - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072119
Enrollment
80
Registered
2024-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with the clinical features of Vatarakta (sandhi shotha(swelling), sandhi shola(pain), sparsh asahatvam (tenderness), twak vaivarnya(discolouration of skin), raga(redness), vidaha(burning sensation), stabdhata(stiffness)) 2.Patients either sex between age group of 21-60 yrs. 3.Patients showing the Serum uric acid level 7 -10mg/dl.

Exclusion criteria

Exclusion criteria: 1.Uncontrolled Diabetes and uncontrolled HTN 2.Subjects pre-diagnosed with autoimmune and infective disease of joints. E.g. tuberculous arthritis 3.Malignancy 4.Genetic Disorder e.g. Duchene muscular dystrophy 5.Pregnant and lactating women 6.History of hypersensitivity to any of the trial drug ingredient.

Design outcomes

Primary

MeasureTime frame
•Improvement in the signs & symptoms (sandhi shotha(swelling)sandhi shola(pain), sparsh asahatvam (tenderness), twak vaivarnya(discolouration of skin), raga(redness), vidaha(burning sensation), stabdhata(stiffness)) of Vatarakta (Chronic Gout).Timepoint: BASELINE AFTER 6 WEEKS AFTER 12 WEEKS

Secondary

MeasureTime frame
Reduction in the level of serum uric acid in the patients having Vatarakta (Chronic Gout). (approx 25% improvement is expected) Improvement in the quality of life of the patient.Timepoint: BASELINE AFTER 6 WEEKS AFTER 12 WEEKS

Countries

India

Contacts

Public ContactDr Rama Kant Yadava

ALL INDIA INSTITUTE OF AYURVEDA

drrky68@gmail.com9412148437

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026